Cementoplasty and the Oncologic Population

JC Hodge
Correspondence: Jacqueline C Hodge, jchodge@rad.mgh.mcgill.ca

ABSTRACT
The first and only description of percutaneous cementoplasty, to date, has been described in the French medical literature in 1994. In this series of 12 cases, radiologists successfully instilled a cement derivative into the acetabulum under fluoroscopic control. As in these cases, the major indication for cementoplasty is to provide pain control and stabilization of an osteolytic lesion. Potential complications include physical or thermal damage to the adjacent neurovascular structures, either during needle positioning or from cement leakage, respectively. Although no absolute contraindications exist, one should proceed cautiously in patients with coagulopathies. Results may be suboptimal as well in patients with pathologic fractures.

Keywords: methyl methacrylate, osteolytic, osteoporosis, metastases
Singapore Med J 2000; 41(8): 407-409